Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
-
The Cell & Gene Therapy CDMO market is growing with rising CGT pipelines, outsourcing, and viral vector demand.
-
VANCOUVER, British Columbia, March 05, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative...
-
Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
-
Miracle Sheets 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying
New York City, NY, March 05, 2026 (GLOBE NEWSWIRE) -- Think about it. Every single night, your sheets are soaking up sweat, body oils, dead skin cells, and bacteria. Within just a few days, your...
-
Gene Editing Therapeutics Market size was valued at US$ 11.13 Million in 2024, expanding at a CAGR of 147.20% from 2025 to 2032.
-
Dublin, March 05, 2026 (GLOBE NEWSWIRE) -- The "Biological Sterilization Monitoring Equipment Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's offering. The...
-
Austin, United States, March 05, 2026 (GLOBE NEWSWIRE) -- Genomics Services Market Size & Growth Analysis: As per SNS Insider Research, The Genomics Services Market size was valued at USD 7.94...
-
5 March 2026 2025 Results Highlights Admiral Group reports record profits for 2025 with strong contributions from across the Group 31 December 202531 December 2024% change vs. 2024Group profit...
-
CHICAGO and FORT WORTH, Texas, March 04, 2026 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on...